Eureka Nanobioengineering
Main Vertical
BioTech, HealthTech
Website
CEO/FOUNDER
Name and Surname
Damian Alvarez Paggi
Linkedin Profile or Bio
Name and Surname
Salvador Ventura
Linkedin Profile or Bio
Name and Surname
Daniel H. Murgida
Linkedin Profile or Bio
Number of people on the Staff
9
Legal Form
Public Limited Company (SA)
Year of Founding
2022
Development Stage
Province
Santa Fe
City
Rosario
Main Business Model
B2B
Problem
The technologies currently in use for disease detection, prevention, and treatment impose restrictions on the scalability, customization, upgradability, cost-effectiveness, accessibility, and sustainability of the solutions needed to manage global health crises.
Solutions Offered - Summary
Modular versatile platform for cost-effective nanobiodevices.
Solutions Offered - Details
The project introduces a modular platform to create scalable, customizable health solutions for pandemics, chronic, and emerging diseases. It ensures rapid and accessible treatments, fostering global equity while enhancing pharmaceutical production. This sustainable approach benefits individuals and companies alike, driving a positive impact on global health.
Technologies Used
Artificial Intelligence
Counterparties of Interest abroad
Accelerator, End Customer
Industries served
Animal Health, Biotechnology, Health, HealthTech
Other industries served
Diagnóstico
Investment Round:
Pre-Seed
Awards/Recognitions
2024 "Emprender en Salud" award, from Mayma and Johnson&Johnson. 2021, Finalist of the "Cesar Milstein" Award (CONICET)
Presentation
E-mail
contact@eurekanbe.tech